ArticleHepatology (Baltimore, Md.)2022

Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma.

Lu Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.